[x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware (State or other jurisdiction of incorporation or organization) | 36-6169860 (I.R.S. Employer Identification No.) |
333 S. Wabash Chicago, Illinois (Address of principal executive offices) | 60604 (Zip Code) |
Large accelerated filer [x] | Accelerated filer [ ] | Non-accelerated filer [ ] (Do not check if a smaller reporting company) | Smaller reporting company [ ] |
Class | Outstanding at April 26, 2013 | |
Common Stock, Par value $2.50 | 269,684,313 |
Item Number | PART I. Financial Information | Page Number |
1. | ||
2. | ||
3. | ||
4. | ||
PART II. Other Information | ||
1. | ||
4. | ||
6. |
Three months ended March 31 | |||||||
(In millions, except per share data) | 2013 | 2012 | |||||
Revenues | |||||||
Net earned premiums | $ | 1,764 | $ | 1,649 | |||
Net investment income | 633 | 648 | |||||
Net realized investment gains (losses): | |||||||
Other-than-temporary impairment losses | (18 | ) | (15 | ) | |||
Portion of other-than-temporary impairments recognized in Other comprehensive income (loss) | — | (12 | ) | ||||
Net other-than-temporary impairment losses recognized in earnings | (18 | ) | (27 | ) | |||
Other net realized investment gains | 46 | 63 | |||||
Net realized investment gains | 28 | 36 | |||||
Other revenues | 78 | 68 | |||||
Total revenues | 2,503 | 2,401 | |||||
Claims, Benefits and Expenses | |||||||
Insurance claims and policyholders’ benefits | 1,429 | 1,381 | |||||
Amortization of deferred acquisition costs | 328 | 295 | |||||
Other operating expenses | 341 | 319 | |||||
Interest | 42 | 42 | |||||
Total claims, benefits and expenses | 2,140 | 2,037 | |||||
Income before income tax | 363 | 364 | |||||
Income tax expense | (113 | ) | (114 | ) | |||
Net income | $ | 250 | $ | 250 | |||
Basic and diluted earnings per share | $ | 0.93 | $ | 0.93 | |||
Dividends per share | $ | 0.20 | $ | 0.15 | |||
Weighted Average Outstanding Common Stock and Common Stock Equivalents | |||||||
Basic | 269.5 | 269.3 | |||||
Diluted | 269.9 | 269.7 |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Other Comprehensive Income (Loss), Net of Tax | |||||||
Changes in: | |||||||
Net unrealized gains on investments with other-than-temporary impairments | $ | 14 | $ | 40 | |||
Net unrealized gains (losses) on other investments | (62 | ) | 217 | ||||
Net unrealized gains (losses) on investments | (48 | ) | 257 | ||||
Foreign currency translation adjustment | (61 | ) | 21 | ||||
Pension and postretirement benefits | 5 | 6 | |||||
Other comprehensive income (loss), net of tax | (104 | ) | 284 | ||||
Net income | 250 | 250 | |||||
Total comprehensive income | $ | 146 | $ | 534 |
March 31, 2013 | December 31, 2012 | ||||||
(In millions, except share data) | |||||||
Assets | |||||||
Investments: | |||||||
Fixed maturity securities at fair value (amortized cost of $38,533 and $38,170) | $ | 42,799 | $ | 42,633 | |||
Equity securities at fair value (cost of $177 and $228) | 201 | 249 | |||||
Limited partnership investments | 2,564 | 2,462 | |||||
Other invested assets | 49 | 59 | |||||
Mortgage loans | 425 | 401 | |||||
Short term investments | 1,555 | 1,832 | |||||
Total investments | 47,593 | 47,636 | |||||
Cash | 123 | 156 | |||||
Reinsurance receivables (less allowance for uncollectible receivables of $71 and $73) | 6,066 | 6,158 | |||||
Insurance receivables (less allowance for uncollectible receivables of $98 and $101) | 1,974 | 1,882 | |||||
Accrued investment income | 476 | 434 | |||||
Deferred acquisition costs | 641 | 598 | |||||
Deferred income taxes | 21 | 93 | |||||
Property and equipment at cost (less accumulated depreciation of $406 and $404) | 323 | 326 | |||||
Goodwill | 151 | 154 | |||||
Other assets (includes $0 and $4 due from Loews Corporation) | 1,080 | 773 | |||||
Separate account business | 279 | 312 | |||||
Total assets | $ | 58,727 | $ | 58,522 | |||
Liabilities | |||||||
Insurance reserves: | |||||||
Claim and claim adjustment expenses | $ | 24,511 | $ | 24,763 | |||
Unearned premiums | 3,759 | 3,610 | |||||
Future policy benefits | 11,469 | 11,475 | |||||
Policyholders’ funds | 154 | 157 | |||||
Short term debt | 13 | 13 | |||||
Long term debt | 2,558 | 2,557 | |||||
Other liabilities (includes $1 and $0 due to Loews Corporation) | 3,579 | 3,321 | |||||
Separate account business | 279 | 312 | |||||
Total liabilities | 46,322 | 46,208 | |||||
Commitments and contingencies (Notes C, G and J) | |||||||
Stockholders' Equity | |||||||
Common stock ($2.50 par value; 500,000,000 shares authorized; 273,040,243 shares issued; 269,681,511 and 269,399,390 shares outstanding) | 683 | 683 | |||||
Additional paid-in capital | 2,138 | 2,146 | |||||
Retained earnings | 8,969 | 8,774 | |||||
Accumulated other comprehensive income | 727 | 831 | |||||
Treasury stock (3,358,732 and 3,640,853 shares), at cost | (92 | ) | (99 | ) | |||
Notes receivable for the issuance of common stock | (20 | ) | (21 | ) | |||
Total stockholders’ equity | 12,405 | 12,314 | |||||
Total liabilities and stockholders' equity | $ | 58,727 | $ | 58,522 |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Cash Flows from Operating Activities | |||||||
Net income | $ | 250 | $ | 250 | |||
Adjustments to reconcile net income to net cash flows provided by operating activities: | |||||||
Loss on disposal of property and equipment | — | 1 | |||||
Deferred income tax expense | 99 | 73 | |||||
Trading portfolio activity | (48 | ) | (6 | ) | |||
Net realized investment gains | (28 | ) | (36 | ) | |||
Equity method investees | (91 | ) | (69 | ) | |||
Amortization of investments | (10 | ) | (23 | ) | |||
Depreciation and amortization | 33 | 20 | |||||
Changes in: | |||||||
Receivables, net | (20 | ) | 53 | ||||
Accrued investment income | (42 | ) | (42 | ) | |||
Deferred acquisition costs | (40 | ) | (15 | ) | |||
Insurance reserves | 79 | 99 | |||||
Other assets | (20 | ) | 73 | ||||
Other liabilities | 16 | (67 | ) | ||||
Other, net | 13 | 1 | |||||
Total adjustments | (59 | ) | 62 | ||||
Net cash flows provided by operating activities | $ | 191 | $ | 312 | |||
Cash Flows from Investing Activities | |||||||
Dispositions: | |||||||
Fixed maturity securities - sales | $ | 1,409 | $ | 1,929 | |||
Fixed maturity securities - maturities, calls and redemptions | 866 | 683 | |||||
Equity securities | 51 | 19 | |||||
Limited partnerships | 58 | 46 | |||||
Mortgage loans | 1 | 1 | |||||
Purchases: | |||||||
Fixed maturity securities | (2,720 | ) | (2,842 | ) | |||
Equity securities | (12 | ) | (12 | ) | |||
Limited partnerships | (41 | ) | (36 | ) | |||
Mortgage loans | (25 | ) | (48 | ) | |||
Change in other investments | 3 | — | |||||
Change in short term investments | 264 | (8 | ) | ||||
Purchases of property and equipment | (21 | ) | (22 | ) | |||
Other, net | 6 | 3 | |||||
Net cash flows used by investing activities | $ | (161 | ) | $ | (287 | ) |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Cash Flows from Financing Activities | |||||||
Dividends paid to common stockholders | $ | (55 | ) | $ | (41 | ) | |
Stock options exercised | 1 | — | |||||
Other, net | (2 | ) | (1 | ) | |||
Net cash flows used by financing activities | $ | (56 | ) | $ | (42 | ) | |
Effect of foreign exchange rate changes on cash | $ | (7 | ) | $ | 1 | ||
Net change in cash | $ | (33 | ) | $ | (16 | ) | |
Cash, beginning of year | 156 | 75 | |||||
Cash, end of period | $ | 123 | $ | 59 |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Common Stock | |||||||
Balance, beginning of period | $ | 683 | $ | 683 | |||
Balance, end of period | 683 | 683 | |||||
Additional Paid-in Capital | |||||||
Balance, beginning of period | 2,146 | 2,141 | |||||
Stock-based compensation | (8 | ) | (1 | ) | |||
Balance, end of period | 2,138 | 2,140 | |||||
Retained Earnings | |||||||
Balance, beginning of period | 8,774 | 8,308 | |||||
Dividends paid to common stockholders | (55 | ) | (41 | ) | |||
Net income | 250 | 250 | |||||
Balance, end of period | 8,969 | 8,517 | |||||
Accumulated Other Comprehensive Income | |||||||
Balance, beginning of period | 831 | 480 | |||||
Other comprehensive income (loss) | (104 | ) | 284 | ||||
Balance, end of period | 727 | 764 | |||||
Treasury Stock | |||||||
Balance, beginning of period | (99 | ) | (102 | ) | |||
Stock-based compensation | 7 | 2 | |||||
Balance, end of period | (92 | ) | (100 | ) | |||
Notes Receivable for the Issuance of Common Stock | |||||||
Balance, beginning of period | (21 | ) | (22 | ) | |||
(Increase) decrease in notes receivable for the issuance of common stock | 1 | (1 | ) | ||||
Balance, end of period | (20 | ) | (23 | ) | |||
Total Stockholders' Equity | $ | 12,405 | $ | 11,981 |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Fixed maturity securities | $ | 499 | $ | 516 | |||
Short term investments | 1 | 1 | |||||
Limited partnership investments | 131 | 130 | |||||
Equity securities | 3 | 4 | |||||
Mortgage loans | 5 | 3 | |||||
Trading portfolio (a) | 5 | 7 | |||||
Other | 1 | 1 | |||||
Gross investment income | 645 | 662 | |||||
Investment expense | (12 | ) | (14 | ) | |||
Net investment income | $ | 633 | $ | 648 |
(a) | There were $1 million of net unrealized gains for the three months ended March 31, 2013 and no net unrealized gains (losses) for the three months ended March 31, 2012 related to changes in fair value of trading securities still held included in net investment income. |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Net realized investment gains (losses): | |||||||
Fixed maturity securities: | |||||||
Gross realized gains | $ | 44 | $ | 69 | |||
Gross realized losses | (12 | ) | (39 | ) | |||
Net realized investment gains (losses) on fixed maturity securities | 32 | 30 | |||||
Equity securities: | |||||||
Gross realized gains | 2 | 3 | |||||
Gross realized losses | (15 | ) | (2 | ) | |||
Net realized investment gains (losses) on equity securities | (13 | ) | 1 | ||||
Derivatives | 2 | (1 | ) | ||||
Short term investments and other | 7 | 6 | |||||
Net realized investment gains (losses) | $ | 28 | $ | 36 |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Fixed maturity securities available-for-sale: | |||||||
Corporate and other bonds | $ | 3 | $ | 10 | |||
Asset-backed - residential mortgage-backed | — | 14 | |||||
U.S. Treasury and obligations of government-sponsored enterprises | — | 1 | |||||
Total fixed maturity securities available-for-sale | 3 | 25 | |||||
Equity securities available-for-sale: | |||||||
Common stock | — | 2 | |||||
Preferred stock | 15 | — | |||||
Total equity securities available-for-sale | 15 | 2 | |||||
Net OTTI losses recognized in earnings | $ | 18 | $ | 27 |
March 31, 2013 | Cost or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | Unrealized OTTI Losses (Gains) | ||||||||||||||
(In millions) | |||||||||||||||||||
Fixed maturity securities available-for-sale: | |||||||||||||||||||
Corporate and other bonds | $ | 19,747 | $ | 2,562 | $ | 18 | $ | 22,291 | $ | — | |||||||||
States, municipalities and political subdivisions | 9,599 | 1,408 | 59 | 10,948 | — | ||||||||||||||
Asset-backed: | |||||||||||||||||||
Residential mortgage-backed | 5,518 | 235 | 70 | 5,683 | (49 | ) | |||||||||||||
Commercial mortgage-backed | 1,853 | 147 | 10 | 1,990 | (3 | ) | |||||||||||||
Other asset-backed | 932 | 23 | — | 955 | — | ||||||||||||||
Total asset-backed | 8,303 | 405 | 80 | 8,628 | (52 | ) | |||||||||||||
U.S. Treasury and obligations of government-sponsored enterprises | 170 | 11 | — | 181 | — | ||||||||||||||
Foreign government | 528 | 24 | — | 552 | — | ||||||||||||||
Redeemable preferred stock | 123 | 14 | 1 | 136 | — | ||||||||||||||
Total fixed maturity securities available-for-sale | 38,470 | 4,424 | 158 | 42,736 | $ | (52 | ) | ||||||||||||
Total fixed maturity securities trading | 63 | — | — | 63 | |||||||||||||||
Equity securities available-for-sale: | |||||||||||||||||||
Common stock | 38 | 17 | — | 55 | |||||||||||||||
Preferred stock | 139 | 7 | — | 146 | |||||||||||||||
Total equity securities available-for-sale | 177 | 24 | — | 201 | |||||||||||||||
Total | $ | 38,710 | $ | 4,448 | $ | 158 | $ | 43,000 |
December 31, 2012 | Cost or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | Unrealized OTTI Losses (Gains) | ||||||||||||||
(In millions) | |||||||||||||||||||
Fixed maturity securities available-for-sale: | |||||||||||||||||||
Corporate and other bonds | $ | 19,530 | $ | 2,698 | $ | 21 | $ | 22,207 | $ | — | |||||||||
States, municipalities and political subdivisions | 9,372 | 1,455 | 44 | 10,783 | — | ||||||||||||||
Asset-backed: | |||||||||||||||||||
Residential mortgage-backed | 5,745 | 246 | 71 | 5,920 | (28 | ) | |||||||||||||
Commercial mortgage-backed | 1,692 | 147 | 17 | 1,822 | (3 | ) | |||||||||||||
Other asset-backed | 929 | 23 | — | 952 | — | ||||||||||||||
Total asset-backed | 8,366 | 416 | 88 | 8,694 | (31 | ) | |||||||||||||
U.S. Treasury and obligations of government-sponsored enterprises | 172 | 11 | 1 | 182 | — | ||||||||||||||
Foreign government | 588 | 25 | — | 613 | — | ||||||||||||||
Redeemable preferred stock | 113 | 13 | 1 | 125 | — | ||||||||||||||
Total fixed maturity securities available-for-sale | 38,141 | 4,618 | 155 | 42,604 | $ | (31 | ) | ||||||||||||
Total fixed maturity securities trading | 29 | — | — | 29 | |||||||||||||||
Equity securities available-for-sale: | |||||||||||||||||||
Common stock | 38 | 14 | — | 52 | |||||||||||||||
Preferred stock | 190 | 7 | — | 197 | |||||||||||||||
Total equity securities available-for-sale | 228 | 21 | — | 249 | |||||||||||||||
Total | $ | 38,398 | $ | 4,639 | $ | 155 | $ | 42,882 |
Less than 12 Months | 12 Months or Longer | Total | |||||||||||||||||||||
March 31, 2013 | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | |||||||||||||||||
(In millions) | |||||||||||||||||||||||
Fixed maturity securities available-for-sale: | |||||||||||||||||||||||
Corporate and other bonds | $ | 951 | $ | 13 | $ | 50 | $ | 5 | $ | 1,001 | $ | 18 | |||||||||||
States, municipalities and political subdivisions | 683 | 16 | 121 | 43 | 804 | 59 | |||||||||||||||||
Asset-backed: | |||||||||||||||||||||||
Residential mortgage-backed | 920 | 19 | 347 | 51 | 1,267 | 70 | |||||||||||||||||
Commercial mortgage-backed | 155 | 2 | 141 | 8 | 296 | 10 | |||||||||||||||||
Total asset-backed | 1,075 | 21 | 488 | 59 | 1,563 | 80 | |||||||||||||||||
Redeemable preferred stock | 34 | 1 | — | — | 34 | 1 | |||||||||||||||||
Total | $ | 2,743 | $ | 51 | $ | 659 | $ | 107 | $ | 3,402 | $ | 158 |
Less than 12 Months | 12 Months or Longer | Total | |||||||||||||||||||||
December 31, 2012 | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | |||||||||||||||||
(In millions) | |||||||||||||||||||||||
Fixed maturity securities available-for-sale: | |||||||||||||||||||||||
Corporate and other bonds | $ | 846 | $ | 13 | $ | 108 | $ | 8 | $ | 954 | $ | 21 | |||||||||||
States, municipalities and political subdivisions | 254 | 5 | 165 | 39 | 419 | 44 | |||||||||||||||||
Asset-backed: | |||||||||||||||||||||||
Residential mortgage-backed | 583 | 5 | 452 | 66 | 1,035 | 71 | |||||||||||||||||
Commercial mortgage-backed | 85 | 2 | 141 | 15 | 226 | 17 | |||||||||||||||||
Total asset-backed | 668 | 7 | 593 | 81 | 1,261 | 88 | |||||||||||||||||
U.S. Treasury and obligations of government-sponsored enterprises | 23 | 1 | — | — | 23 | 1 | |||||||||||||||||
Redeemable preferred stock | 28 | 1 | — | — | 28 | 1 | |||||||||||||||||
Total | $ | 1,819 | $ | 27 | $ | 866 | $ | 128 | $ | 2,685 | $ | 155 |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Beginning balance of credit losses on fixed maturity securities | $ | 95 | $ | 92 | |||
Additional credit losses for securities for which an OTTI loss was previously recognized | — | 11 | |||||
Credit losses for securities for which an OTTI loss was not previously recognized | — | 1 | |||||
Reductions for securities sold during the period | (3 | ) | (4 | ) | |||
Ending balance of credit losses on fixed maturity securities | $ | 92 | $ | 100 |
March 31, 2013 | December 31, 2012 | ||||||||||||||
(In millions) | Cost or Amortized Cost | Estimated Fair Value | Cost or Amortized Cost | Estimated Fair Value | |||||||||||
Due in one year or less | $ | 1,783 | $ | 1,819 | $ | 1,648 | $ | 1,665 | |||||||
Due after one year through five years | 12,916 | 13,731 | 13,603 | 14,442 | |||||||||||
Due after five years through ten years | 9,430 | 10,267 | 8,726 | 9,555 | |||||||||||
Due after ten years | 14,341 | 16,919 | 14,164 | 16,942 | |||||||||||
Total | $ | 38,470 | $ | 42,736 | $ | 38,141 | $ | 42,604 |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Without hedge designation | |||||||
Currency forwards | $ | 2 | $ | (1 | ) | ||
Total without hedge designation | 2 | (1 | ) | ||||
Trading activities | |||||||
Futures sold, not yet purchased | — | 1 | |||||
Total | $ | 2 | $ | — |
March 31, 2013 | Contractual/ Notional Amount | Estimated Fair Value | |||||||||
(In millions) | Asset | (Liability) | |||||||||
Without hedge designation | |||||||||||
Credit default swaps - purchased protection | $ | 20 | $ | — | $ | (1 | ) | ||||
Currency forwards | 43 | 1 | — | ||||||||
Forward commitments for mortgage-backed securities | 78 | — | — | ||||||||
Equity warrants | 5 | — | — | ||||||||
Total | $ | 146 | $ | 1 | $ | (1 | ) |
December 31, 2012 | Contractual/ Notional Amount | Estimated Fair Value | |||||||||
(In millions) | Asset | (Liability) | |||||||||
Without hedge designation | |||||||||||
Credit default swaps - purchased protection | $ | 20 | $ | — | $ | (1 | ) | ||||
Currency forwards | 59 | — | (2 | ) | |||||||
Equity warrants | 5 | — | — | ||||||||
Total | $ | 84 | $ | — | $ | (3 | ) |
March 31, 2013 | Total Assets/(Liabilities) at Fair Value | ||||||||||||||
(In millions) | Level 1 | Level 2 | Level 3 | ||||||||||||
Assets | |||||||||||||||
Fixed maturity securities: | |||||||||||||||
Corporate and other bonds | $ | 32 | $ | 22,020 | $ | 302 | $ | 22,354 | |||||||
States, municipalities and political subdivisions | — | 10,819 | 129 | 10,948 | |||||||||||
Asset-backed: | |||||||||||||||
Residential mortgage-backed | — | 5,233 | 450 | 5,683 | |||||||||||
Commercial mortgage-backed | — | 1,813 | 177 | 1,990 | |||||||||||
Other asset-backed | — | 559 | 396 | 955 | |||||||||||
Total asset-backed | — | 7,605 | 1,023 | 8,628 | |||||||||||
U.S. Treasury and obligations of government-sponsored enterprises | 155 | 26 | — | 181 | |||||||||||
Foreign government | 104 | 448 | — | 552 | |||||||||||
Redeemable preferred stock | 51 | 59 | 26 | 136 | |||||||||||
Total fixed maturity securities | 342 | 40,977 | 1,480 | 42,799 | |||||||||||
Equity securities | 120 | 62 | 19 | 201 | |||||||||||
Other invested assets | — | 49 | — | 49 | |||||||||||
Short term investments | 1,102 | 397 | 5 | 1,504 | |||||||||||
Life settlement contracts, included in Other assets | — | — | 95 | 95 | |||||||||||
Separate account business | 11 | 266 | 2 | 279 | |||||||||||
Total assets | $ | 1,575 | $ | 41,751 | $ | 1,601 | $ | 44,927 | |||||||
Liabilities | |||||||||||||||
Derivative financial instruments, included in Other liabilities | $ | — | $ | — | $ | (1 | ) | $ | (1 | ) | |||||
Total liabilities | $ | — | $ | — | $ | (1 | ) | $ | (1 | ) |
December 31, 2012 | Total Assets/(Liabilities) at Fair Value | ||||||||||||||
(In millions) | Level 1 | Level 2 | Level 3 | ||||||||||||
Assets | |||||||||||||||
Fixed maturity securities: | |||||||||||||||
Corporate and other bonds | $ | 6 | $ | 22,011 | $ | 219 | $ | 22,236 | |||||||
States, municipalities and political subdivisions | — | 10,687 | 96 | 10,783 | |||||||||||
Asset-backed: | |||||||||||||||
Residential mortgage-backed | — | 5,507 | 413 | 5,920 | |||||||||||
Commercial mortgage-backed | — | 1,693 | 129 | 1,822 | |||||||||||
Other asset-backed | — | 584 | 368 | 952 | |||||||||||
Total asset-backed | — | 7,784 | 910 | 8,694 | |||||||||||
U.S. Treasury and obligations of government-sponsored enterprises | 158 | 24 | — | 182 | |||||||||||
Foreign government | 140 | 473 | — | 613 | |||||||||||
Redeemable preferred stock | 40 | 59 | 26 | 125 | |||||||||||
Total fixed maturity securities | 344 | 41,038 | 1,251 | 42,633 | |||||||||||
Equity securities | 117 | 98 | 34 | 249 | |||||||||||
Other invested assets | — | 58 | 1 | 59 | |||||||||||
Short term investments | 987 | 799 | 6 | 1,792 | |||||||||||
Life settlement contracts, included in Other assets | — | — | 100 | 100 | |||||||||||
Separate account business | 4 | 306 | 2 | 312 | |||||||||||
Total assets | $ | 1,452 | $ | 42,299 | $ | 1,394 | $ | 45,145 | |||||||
Liabilities | |||||||||||||||
Derivative financial instruments, included in Other liabilities | $ | — | $ | (2 | ) | $ | (1 | ) | $ | (3 | ) | ||||
Total liabilities | $ | — | $ | (2 | ) | $ | (1 | ) | $ | (3 | ) |
Level 3 (In millions) | Balance at January 1, 2013 | Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss)* | Net change in unrealized appreciation (depreciation) included in other comprehensive income (loss) | Purchases | Sales | Settlements | Transfers into Level 3 | Transfers out of Level 3 | Balance at March 31, 2013 | Unrealized gains (losses) on Level 3 assets and liabilities held at March 31, 2013 recognized in net income (loss)* | |||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||
Corporate and other bonds | $ | 219 | $ | — | $ | 2 | $ | 110 | $ | (17 | ) | $ | (20 | ) | $ | 26 | $ | (18 | ) | $ | 302 | $ | (1 | ) | |||||||||||||||
States, municipalities and political subdivisions | 96 | (3 | ) | — | 85 | (47 | ) | (2 | ) | — | — | 129 | — | ||||||||||||||||||||||||||
Asset-backed: | |||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 413 | 3 | — | 61 | — | (11 | ) | — | (16 | ) | 450 | — | |||||||||||||||||||||||||||
Commercial mortgage-backed | 129 | 1 | 5 | 73 | — | (7 | ) | — | (24 | ) | 177 | — | |||||||||||||||||||||||||||
Other asset-backed | 368 | 3 | 1 | 136 | (99 | ) | (13 | ) | — | — | 396 | — | |||||||||||||||||||||||||||
Total asset-backed | 910 | 7 | 6 | 270 | (99 | ) | (31 | ) | — | (40 | ) | 1,023 | — | ||||||||||||||||||||||||||
Redeemable preferred stock | 26 | — | — | — | — | — | — | — | 26 | — | |||||||||||||||||||||||||||||
Total fixed maturity securities | 1,251 | 4 | 8 | 465 | (163 | ) | (53 | ) | 26 | (58 | ) | 1,480 | (1 | ) | |||||||||||||||||||||||||
Equity securities | 34 | (15 | ) | 1 | — | — | — | — | (1 | ) | 19 | (15 | ) | ||||||||||||||||||||||||||
Other invested assets, including derivatives, net | — | — | — | — | (1 | ) | — | — | — | (1 | ) | — | |||||||||||||||||||||||||||
Short term investments | 6 | — | — | — | (1 | ) | — | — | — | 5 | — | ||||||||||||||||||||||||||||
Life settlement contracts | 100 | 7 | — | — | — | (12 | ) | — | — | 95 | — | ||||||||||||||||||||||||||||
Separate account business | 2 | — | — | — | — | — | — | — | 2 | — | |||||||||||||||||||||||||||||
Total | $ | 1,393 | $ | (4 | ) | $ | 9 | $ | 465 | $ | (165 | ) | $ | (65 | ) | $ | 26 | $ | (59 | ) | $ | 1,600 | $ | (16 | ) |
Level 3 (In millions) | Balance at January 1, 2012 | Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss)* | Net change in unrealized appreciation (depreciation) included in other comprehensive income (loss) | Purchases | Sales | Settlements | Transfers into Level 3 | Transfers out of Level 3 | Balance at March 31, 2012 | Unrealized gains (losses) on Level 3 assets and liabilities held at March 31, 2012 recognized in net income (loss)* | |||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||
Corporate and other bonds | $ | 482 | $ | 3 | $ | 4 | $ | 79 | $ | (86 | ) | $ | (19 | ) | $ | 33 | $ | (10 | ) | $ | 486 | $ | — | ||||||||||||||||
States, municipalities and political subdivisions | 171 | — | 2 | — | — | — | — | — | 173 | — | |||||||||||||||||||||||||||||
Asset-backed: | |||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 452 | 1 | (4 | ) | 38 | — | (7 | ) | — | (33 | ) | 447 | — | ||||||||||||||||||||||||||
Commercial mortgage-backed | 59 | — | 4 | 42 | — | — | — | — | 105 | — | |||||||||||||||||||||||||||||
Other asset-backed | 343 | 4 | 4 | 176 | (77 | ) | (25 | ) | — | (41 | ) | 384 | — | ||||||||||||||||||||||||||
Total asset-backed | 854 | 5 | 4 | 256 | (77 | ) | (32 | ) | — | (74 | ) | 936 | — | ||||||||||||||||||||||||||
Redeemable preferred stock | — | — | — | 53 | — | — | — | — | 53 | — | |||||||||||||||||||||||||||||
Total fixed maturity securities | 1,507 | 8 | 10 | 388 | (163 | ) | (51 | ) | 33 | (84 | ) | 1,648 | — | ||||||||||||||||||||||||||
Equity securities | 67 | — | (3 | ) | 11 | (1 | ) | — | — | — | 74 | (2 | ) | ||||||||||||||||||||||||||
Other invested assets, including derivatives, net | 10 | — | — | — | — | — | — | — | 10 | — | |||||||||||||||||||||||||||||
Short term investments | 27 | — | — | 12 | — | (39 | ) | — | — | — | — | ||||||||||||||||||||||||||||
Life settlement contracts | 117 | 3 | — | — | — | (5 | ) | — | — | 115 | (1 | ) | |||||||||||||||||||||||||||
Separate account business | 23 | — | — | — | (19 | ) | — | — | — | 4 | — | ||||||||||||||||||||||||||||
Total | $ | 1,751 | $ | 11 | $ | 7 | $ | 411 | $ | (183 | ) | $ | (95 | ) | $ | 33 | $ | (84 | ) | $ | 1,851 | $ | (3 | ) |
Major Category of Assets and Liabilities | Condensed Consolidated Statements of Operations Line Items | |
Fixed maturity securities available-for-sale | Net realized investment gains (losses) | |
Fixed maturity securities trading | Net investment income | |
Equity securities | Net realized investment gains (losses) | |
Other invested assets - Derivative financial instruments held in a trading portfolio | Net investment income | |
Other invested assets - Derivative financial instruments not held in a trading portfolio | Net realized investment gains (losses) | |
Other invested assets - Overseas deposits | Net investment income | |
Life settlement contracts | Other revenues |
Assets (In millions) | Fair Value at March 31, 2013 | Valuation Technique(s) | Unobservable Input(s) | Range (Weighted Average) | |||||
Fixed maturity securities | $ | 78 | Discounted cash flow | Expected call date | 3.0 - 4.6 years (4.0 years) | ||||
Credit spread adjustment | 0.02% - 0.48% (0.17%) | ||||||||
$ | 97 | Market approach | Private offering price | $34.70 - $122.09 ($102.97) | |||||
Equity securities | $ | 19 | Market approach | Private offering price | $33.73 - $3,970.99 per share ($1,114.32 per share) | ||||
Life settlement contracts | $ | 95 | Discounted cash flow | Discount rate risk premium | 9% | ||||
Mortality assumption | 69% - 883% (209.2%) |
Assets (In millions) | Fair Value at December 31, 2012 | Valuation Technique(s) | Unobservable Input(s) | Range (Weighted Average) | |||||
Fixed maturity securities | $ | 121 | Discounted cash flow | Expected call date | 3.3 - 5.3 years (4.3 years) | ||||
Credit spread adjustment | 0.02% - 0.48% (0.17%) | ||||||||
$ | 72 | Market approach | Private offering price | $42.39 - $102.32 ($100.11) | |||||
Equity securities | $ | 34 | Market approach | Private offering price | $4.54 - $3,842.00 per share ($571.17 per share) | ||||
Life settlement contracts | $ | 100 | Discounted cash flow | Discount rate risk premium | 9% | ||||
Mortality assumption | 69% - 883% (208.9%) |
March 31, 2013 | Carrying Amount | Estimated Fair Value | |||||||||||||||||
(In millions) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||
Financial assets | |||||||||||||||||||
Notes receivable for the issuance of common stock | $ | 20 | $ | — | $ | — | $ | 20 | $ | 20 | |||||||||
Mortgage loans | 425 | — | — | 449 | 449 | ||||||||||||||
Financial liabilities | |||||||||||||||||||
Premium deposits and annuity contracts | $ | 96 | $ | — | $ | — | $ | 100 | $ | 100 | |||||||||
Short term debt | 13 | — | 13 | — | 13 | ||||||||||||||
Long term debt | 2,558 | — | 3,016 | — | 3,016 |
December 31, 2012 | Carrying Amount | Estimated Fair Value | |||||||||||||||||
(In millions) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||
Financial assets | |||||||||||||||||||
Notes receivable for the issuance of common stock | $ | 21 | $ | — | $ | — | $ | 21 | $ | 21 | |||||||||
Mortgage loans | 401 | — | — | 418 | 418 | ||||||||||||||
Financial liabilities | |||||||||||||||||||
Premium deposits and annuity contracts | $ | 100 | $ | — | $ | — | $ | 104 | $ | 104 | |||||||||
Short term debt | 13 | — | 13 | — | 13 | ||||||||||||||
Long term debt | 2,557 | — | 3,016 | — | 3,016 |
Three months ended March 31, 2013 | |||||||||||||||||||
(In millions) | CNA Specialty | CNA Commercial | Hardy | Corporate & Other Non-Core | Total | ||||||||||||||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ | (15 | ) | $ | (11 | ) | $ | (1 | ) | $ | 1 | $ | (26 | ) | |||||
Pretax (favorable) unfavorable premium development | (8 | ) | (10 | ) | 4 | 1 | (13 | ) | |||||||||||
Total pretax (favorable) unfavorable net prior year development | $ | (23 | ) | $ | (21 | ) | $ | 3 | $ | 2 | $ | (39 | ) |
Three months ended March 31, 2012 | |||||||||||||||
(In millions) | CNA Specialty | CNA Commercial | Corporate & Other Non-Core | Total | |||||||||||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ | (6 | ) | $ | (14 | ) | $ | 2 | $ | (18 | ) | ||||
Pretax (favorable) unfavorable premium development | (9 | ) | (17 | ) | 1 | (25 | ) | ||||||||
Total pretax (favorable) unfavorable net prior year development | $ | (15 | ) | $ | (31 | ) | $ | 3 | $ | (43 | ) |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development: | |||||||
Medical Professional Liability | $ | (3 | ) | $ | (6 | ) | |
Other Professional Liability | (1 | ) | 4 | ||||
Surety | 1 | 1 | |||||
Warranty | — | (1 | ) | ||||
Other | (12 | ) | (4 | ) | |||
Total pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ | (15 | ) | $ | (6 | ) |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development: | |||||||
Commercial Auto | $ | (5 | ) | $ | — | ||
General Liability | (21 | ) | 8 | ||||
Workers' Compensation | 25 | (19 | ) | ||||
Property and Other | (10 | ) | (3 | ) | |||
Total pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ | (11 | ) | $ | (14 | ) |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Pension cost (benefit) | |||||||
Service cost | $ | 3 | $ | 3 | |||
Interest cost on projected benefit obligation | 30 | 34 | |||||
Expected return on plan assets | (45 | ) | (43 | ) | |||
Amortization of net actuarial (gain) loss | 12 | 10 | |||||
Net periodic pension cost (benefit) | $ | — | $ | 4 | |||
Postretirement cost (benefit) | |||||||
Amortization of prior service credit | $ | (4 | ) | $ | (4 | ) | |
Net periodic postretirement cost (benefit) | $ | (4 | ) | $ | (4 | ) |
March 31, 2013 | December 31, 2012 | ||||||||||||||
(In millions) | Gross Carrying Amount | Accumulated Amortization | Gross Carrying Amount | Accumulated Amortization | |||||||||||
Finite-lived intangible assets: | |||||||||||||||
Value of business acquired | $ | 59 | $ | 52 | $ | 62 | $ | 43 | |||||||
Trade name | 8 | 1 | 8 | — | |||||||||||
Distribution channel | 12 | 1 | 13 | — | |||||||||||
Total finite-lived intangible assets | 79 | 54 | 83 | 43 | |||||||||||
Indefinite-lived intangible assets | 69 | 73 | |||||||||||||
Total other intangible assets | $ | 148 | $ | 54 | $ | 156 | $ | 43 |
Three months ended March 31, 2013 | CNA Specialty | CNA Commercial | Hardy | Life & Group Non-Core | Corporate & Other Non-Core | ||||||||||||||||||||||
(In millions) | Eliminations | Total | |||||||||||||||||||||||||
Operating revenues | |||||||||||||||||||||||||||
Net earned premiums | $ | 723 | $ | 837 | $ | 64 | $ | 141 | $ | — | $ | (1 | ) | $ | 1,764 | ||||||||||||
Net investment income | 170 | 250 | 1 | 204 | 8 | — | 633 | ||||||||||||||||||||
Other revenues | 60 | 10 | 1 | 4 | 3 | — | 78 | ||||||||||||||||||||
Total operating revenues | 953 | 1,097 | 66 | 349 | 11 | (1 | ) | 2,475 | |||||||||||||||||||
Claims, Benefits and Expenses | |||||||||||||||||||||||||||
Net incurred claims and benefits | 465 | 600 | 31 | 325 | 4 | — | 1,425 | ||||||||||||||||||||
Policyholders’ dividends | 1 | 2 | — | 1 | — | — | 4 | ||||||||||||||||||||
Amortization of deferred acquisition costs | 150 | 149 | 21 | 8 | — | — | 328 | ||||||||||||||||||||
Other insurance related expenses | 71 | 143 | 16 | 33 | — | (1 | ) | 262 | |||||||||||||||||||
Other expenses | 54 | 9 | 7 | 5 | 46 | — | 121 | ||||||||||||||||||||
Total claims, benefits and expenses | 741 | 903 | 75 | 372 | 50 | (1 | ) | 2,140 | |||||||||||||||||||
Operating income (loss) before income tax | 212 | 194 | (9 | ) | (23 | ) | (39 | ) | — | 335 | |||||||||||||||||
Income tax (expense) benefit on operating income (loss) | (72 | ) | (69 | ) | 1 | 23 | 13 | — | (104 | ) | |||||||||||||||||
Net operating income (loss) | 140 | 125 | (8 | ) | — | (26 | ) | — | 231 | ||||||||||||||||||
Net realized investment gains (losses) | 3 | 4 | 1 | 14 | 6 | — | 28 | ||||||||||||||||||||
Income tax (expense) benefit on net realized investment gains (losses) | (1 | ) | (1 | ) | — | (5 | ) | (2 | ) | — | (9 | ) | |||||||||||||||
Net realized investment gains (losses), after-tax | 2 | 3 | 1 | 9 | 4 | — | 19 | ||||||||||||||||||||
Net income (loss) | $ | 142 | $ | 128 | $ | (7 | ) | $ | 9 | $ | (22 | ) | $ | — | $ | 250 |
March 31, 2013 | |||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||
Reinsurance receivables | $ | 662 | $ | 1,170 | $ | 251 | $ | 1,273 | $ | 2,781 | $ | — | $ | 6,137 | |||||||||||||
Insurance receivables | $ | 707 | $ | 1,168 | $ | 181 | $ | 13 | $ | 3 | $ | — | $ | 2,072 | |||||||||||||
Deferred acquisition costs | $ | 313 | $ | 287 | $ | 41 | $ | — | $ | — | $ | — | $ | 641 | |||||||||||||
Goodwill | $ | 117 | $ | — | $ | 34 | $ | — | $ | — | $ | — | $ | 151 | |||||||||||||
Insurance reserves | |||||||||||||||||||||||||||
Claim and claim adjustment expenses | $ | 6,807 | $ | 11,105 | $ | 470 | $ | 3,031 | $ | 3,098 | $ | — | $ | 24,511 | |||||||||||||
Unearned premiums | 1,770 | 1,629 | 218 | 143 | — | (1 | ) | 3,759 | |||||||||||||||||||
Future policy benefits | — | — | — | 11,469 | — | — | 11,469 | ||||||||||||||||||||
Policyholders’ funds | 9 | 14 | — | 131 | — | — | 154 |
Three months ended March 31, 2012 | CNA Specialty | CNA Commercial | Hardy | Life & Group Non-Core | Corporate & Other Non-Core | ||||||||||||||||||||
(In millions) | Eliminations | Total | |||||||||||||||||||||||
Operating revenues | |||||||||||||||||||||||||
Net earned premiums | $ | 706 | $ | 803 | $ | 141 | $ | (1 | ) | $ | — | $ | 1,649 | ||||||||||||
Net investment income | 175 | 265 | 198 | 10 | — | 648 | |||||||||||||||||||
Other revenues | 56 | 9 | (2 | ) | 5 | — | 68 | ||||||||||||||||||
Total operating revenues | 937 | 1,077 | 337 | 14 | — | 2,365 | |||||||||||||||||||
Claims, Benefits and Expenses | |||||||||||||||||||||||||
Net incurred claims and benefits | 468 | 567 | 336 | 7 | — | 1,378 | |||||||||||||||||||
Policyholders’ dividends | (2 | ) | 3 | 2 | — | — | 3 | ||||||||||||||||||
Amortization of deferred acquisition costs | 148 | 139 | 8 | — | — | 295 | |||||||||||||||||||
Other insurance related expenses | 72 | 144 | 35 | (1 | ) | — | 250 | ||||||||||||||||||
Other expenses | 50 | 7 | 6 | 48 | — | 111 | |||||||||||||||||||
Total claims, benefits and expenses | 736 | 860 | 387 | 54 | — | 2,037 | |||||||||||||||||||
Operating income (loss) before income tax | 201 | 217 | (50 | ) | (40 | ) | — | 328 | |||||||||||||||||
Income tax (expense) benefit on operating income (loss) | (69 | ) | (78 | ) | 31 | 14 | — | (102 | ) | ||||||||||||||||
Net operating income (loss) | 132 | 139 | (19 | ) | (26 | ) | — | 226 | |||||||||||||||||
Net realized investment gains (losses) | 8 | 11 | 13 | 4 | — | 36 | |||||||||||||||||||
Income tax (expense) benefit on net realized investment gains (losses) | (2 | ) | (4 | ) | (5 | ) | (1 | ) | — | (12 | ) | ||||||||||||||
Net realized investment gains (losses), after-tax | 6 | 7 | 8 | 3 | — | 24 | |||||||||||||||||||
Net income (loss) | $ | 138 | $ | 146 | $ | (11 | ) | $ | (23 | ) | $ | — | $ | 250 |
December 31, 2012 | |||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||
Reinsurance receivables | $ | 665 | $ | 1,155 | $ | 294 | $ | 1,273 | $ | 2,844 | $ | — | $ | 6,231 | |||||||||||||
Insurance receivables | $ | 673 | $ | 1,116 | $ | 181 | $ | 9 | $ | 4 | $ | — | $ | 1,983 | |||||||||||||
Deferred acquisition costs | $ | 300 | $ | 269 | $ | 29 | $ | — | $ | — | $ | — | $ | 598 | |||||||||||||
Goodwill | $ | 117 | $ | — | $ | 37 | $ | — | $ | — | $ | — | $ | 154 | |||||||||||||
Insurance reserves | |||||||||||||||||||||||||||
Claim and claim adjustment expenses | $ | 6,748 | $ | 11,326 | $ | 521 | $ | 3,006 | $ | 3,162 | $ | — | $ | 24,763 | |||||||||||||
Unearned premiums | 1,685 | 1,569 | 222 | 134 | — | — | 3,610 | ||||||||||||||||||||
Future policy benefits | — | — | — | 11,475 | — | — | 11,475 | ||||||||||||||||||||
Policyholders’ funds | 8 | 15 | — | 134 | — | — | 157 |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
CNA Specialty | |||||||
International | $ | 59 | $ | 57 | |||
Professional & Management Liability | 700 | 694 | |||||
Surety | 116 | 119 | |||||
Warranty & Alternative Risks | 81 | 75 | |||||
CNA Specialty revenues | 956 | 945 | |||||
CNA Commercial | |||||||
Commercial Insurance | 826 | 835 | |||||
International | 93 | 91 | |||||
Small Business | 182 | 162 | |||||
CNA Commercial revenues | 1,101 | 1,088 | |||||
Hardy revenues | 67 | ||||||
Life & Group Non-Core | |||||||
Health | 298 | 291 | |||||
Life & Annuity | 61 | 60 | |||||
Other | 4 | (1 | ) | ||||
Life & Group Non-Core revenues | 363 | 350 | |||||
Corporate & Other Non-Core revenues | 17 | 18 | |||||
Eliminations | (1 | ) | — | ||||
Total revenues | $ | 2,503 | $ | 2,401 |
(In millions) | Net unrealized gains (losses) on investments with OTTI losses | Net unrealized gains (losses) on other investments | Pension and postretirement benefits | Cumulative foreign currency translation adjustment | Total | ||||||||||||||
Balance at January 1, 2013 | $ | 20 | $ | 1,371 | $ | (721 | ) | $ | 161 | $ | 831 | ||||||||
Other comprehensive income (loss) before reclassifications | 14 | (49 | ) | — | (61 | ) | (96 | ) | |||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) after tax (expense) benefit of $0, $(6), $3, $0, and $(3) | — | 13 | (5 | ) | — | 8 | |||||||||||||
Other comprehensive income (loss) after tax (expense) benefit of $(7), $35, $(3), $0, and $25 | 14 | (62 | ) | 5 | (61 | ) | (104 | ) | |||||||||||
Balance at March 31, 2013 | $ | 34 | $ | 1,309 | $ | (716 | ) | $ | 100 | $ | 727 |
Component of AOCI | Condensed Consolidated Statements of Operations Line Item Affected by Reclassifications | |
Net unrealized gains (losses) on investments with OTTI losses | Net realized investment gains (losses) | |
Net unrealized gains (losses) on other investments | Net realized investment gains (losses) | |
Pension and postretirement benefits | Other operating expenses |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Operating Revenues | |||||||
Net earned premiums | $ | 1,764 | $ | 1,649 | |||
Net investment income | 633 | 648 | |||||
Other revenues | 78 | 68 | |||||
Total operating revenues | 2,475 | 2,365 | |||||
Claims, Benefits and Expenses | |||||||
Net incurred claims and benefits | 1,425 | 1,378 | |||||
Policyholders' dividends | 4 | 3 | |||||
Amortization of deferred acquisition costs | 328 | 295 | |||||
Other insurance related expenses | 262 | 250 | |||||
Other expenses | 121 | 111 | |||||
Total claims, benefits and expenses | 2,140 | 2,037 | |||||
Operating income (loss) before income tax | 335 | 328 | |||||
Income tax (expense) benefit on operating income (loss) | (104 | ) | (102 | ) | |||
Net operating income (loss) | 231 | 226 | |||||
Net realized investment gains (losses) | 28 | 36 | |||||
Income tax (expense) benefit on net realized investment gains (losses) | (9 | ) | (12 | ) | |||
Net realized investment gains (losses), after-tax | 19 | 24 | |||||
Net income (loss) | $ | 250 | $ | 250 |
• | Insurance Reserves |
• | Reinsurance and Insurance Receivables |
• | Valuation of Investments and Impairment of Securities |
• | Long Term Care Products and Payout Annuity Contracts |
• | Pension and Postretirement Benefit Obligations |
• | Income Taxes |
Three months ended March 31 | |||||||
(In millions, except ratios) | 2013 | 2012 | |||||
Net written premiums | $ | 803 | $ | 765 | |||
Net earned premiums | 723 | 706 | |||||
Net investment income | 170 | 175 | |||||
Net operating income (loss) | 140 | 132 | |||||
Net realized investment gains (losses), after-tax | 2 | 6 | |||||
Net income (loss) | 142 | 138 | |||||
Ratios | |||||||
Loss and loss adjustment expense | 64.3 | % | 66.3 | % | |||
Expense | 30.5 | 31.3 | |||||
Dividend | 0.2 | (0.3 | ) | ||||
Combined | 95.0 | % | 97.3 | % |
March 31, 2013 | December 31, 2012 | ||||||
(In millions) | |||||||
Gross Case Reserves | $ | 2,298 | $ | 2,292 | |||
Gross IBNR Reserves | 4,509 | 4,456 | |||||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | $ | 6,807 | $ | 6,748 | |||
Net Case Reserves | $ | 2,017 | $ | 2,008 | |||
Net IBNR Reserves | 4,136 | 4,104 | |||||
Total Net Carried Claim and Claim Adjustment Expense Reserves | $ | 6,153 | $ | 6,112 |
Three months ended March 31 | |||||||
(In millions, except ratios) | 2013 | 2012 | |||||
Net written premiums | $ | 918 | $ | 843 | |||
Net earned premiums | 837 | 803 | |||||
Net investment income | 250 | 265 | |||||
Net operating income (loss) | 125 | 139 | |||||
Net realized investment gains (losses), after-tax | 3 | 7 | |||||
Net income (loss) | 128 | 146 | |||||
Ratios | |||||||
Loss and loss adjustment expense | 71.7 | % | 70.7 | % | |||
Expense | 35.0 | 35.1 | |||||
Dividend | 0.1 | 0.4 | |||||
Combined | 106.8 | % | 106.2 | % |
(In millions) | March 31, 2013 | December 31, 2012 | |||||
Gross Case Reserves | $ | 6,083 | $ | 6,146 | |||
Gross IBNR Reserves | 5,022 | 5,180 | |||||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | $ | 11,105 | $ | 11,326 | |||
Net Case Reserves | $ | 5,553 | $ | 5,611 | |||
Net IBNR Reserves | 4,432 | 4,600 | |||||
Total Net Carried Claim and Claim Adjustment Expense Reserves | $ | 9,985 | $ | 10,211 |
Three months ended March 31 | |||
(In millions, except ratios) | 2013 | ||
Net written premiums | $ | 55 | |
Net earned premiums | 64 | ||
Net investment income | 1 | ||
Net operating income (loss) | (8 | ) | |
Net realized investment gains (losses), after-tax | 1 | ||
Net income (loss) | (7 | ) | |
Ratios | |||
Loss and loss adjustment expense | 48.7 | % | |
Expense | 56.8 | ||
Dividend | — | ||
Combined | 105.5 | % |
(In millions) | March 31, 2013 | December 31, 2012 | |||||
Gross Case Reserves | $ | 320 | $ | 333 | |||
Gross IBNR Reserves | 150 | 188 | |||||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | $ | 470 | $ | 521 | |||
Net Case Reserves | $ | 180 | $ | 192 | |||
Net IBNR Reserves | 78 | 82 | |||||
Total Net Carried Claim and Claim Adjustment Expense Reserves | $ | 258 | $ | 274 |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Net earned premiums | $ | 141 | $ | 141 | |||
Net investment income | 204 | 198 | |||||
Net operating income (loss) | — | (19 | ) | ||||
Net realized investment gains (losses), after-tax | 9 | 8 | |||||
Net income (loss) | 9 | (11 | ) |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Net investment income | $ | 8 | $ | 10 | |||
Net operating income (loss) | (26 | ) | (26 | ) | |||
Net realized investment gains (losses), after-tax | 4 | 3 | |||||
Net income (loss) | (22 | ) | (23 | ) |
(In millions) | March 31, 2013 | December 31, 2012 | |||||
Gross Case Reserves | $ | 1,177 | $ | 1,207 | |||
Gross IBNR Reserves | 1,921 | 1,955 | |||||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | $ | 3,098 | $ | 3,162 | |||
Net Case Reserves | $ | 290 | $ | 292 | |||
Net IBNR Reserves | 211 | 220 | |||||
Total Net Carried Claim and Claim Adjustment Expense Reserves | $ | 501 | $ | 512 |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Fixed maturity securities | $ | 499 | $ | 516 | |||
Short term investments | 1 | 1 | |||||
Limited partnership investments | 131 | 130 | |||||
Equity securities | 3 | 4 | |||||
Mortgage loans | 5 | 3 | |||||
Trading portfolio | 5 | 7 | |||||
Other | 1 | 1 | |||||
Gross investment income | 645 | 662 | |||||
Investment expense | (12 | ) | (14 | ) | |||
Net investment income | $ | 633 | $ | 648 |
Three months ended March 31 | |||||||
(In millions) | 2013 | 2012 | |||||
Fixed maturity securities: | |||||||
Corporate and other bonds | $ | 31 | $ | 23 | |||
States, municipalities and political subdivisions | (2 | ) | 15 | ||||
Asset-backed | 3 | (12 | ) | ||||
U.S. Treasury and obligations of government-sponsored enterprises | — | 1 | |||||
Foreign government | — | 3 | |||||
Total fixed maturity securities | 32 | 30 | |||||
Equity securities | (13 | ) | 1 | ||||
Derivative securities | 2 | (1 | ) | ||||
Short term investments and other | 7 | 6 | |||||
Net realized investment gains (losses) | 28 | 36 | |||||
Income tax (expense) benefit on net realized investment gains (losses) | (9 | ) | (12 | ) | |||
Net realized investment gains (losses), after-tax | $ | 19 | $ | 24 |
(In millions) | March 31, 2013 | % | December 31, 2012 | % | |||||||||
U.S. Government, Government agencies and Government-sponsored enterprises | $ | 4,230 | 10 | % | $ | 4,540 | 11 | % | |||||
AAA rated | 3,128 | 7 | 3,224 | 8 | |||||||||
AA and A rated | 19,875 | 46 | 19,305 | 45 | |||||||||
BBB rated | 11,911 | 28 | 11,997 | 28 | |||||||||
Non-investment grade | 3,655 | 9 | 3,567 | 8 | |||||||||
Total | $ | 42,799 | 100 | % | $ | 42,633 | 100 | % |
(In millions) | March 31, 2013 | % | December 31, 2012 | % | |||||||||
BB | $ | 1,593 | 43 | % | $ | 1,529 | 43 | % | |||||
B | 1,087 | 30 | 1,075 | 30 | |||||||||
CCC - C | 757 | 21 | 724 | 20 | |||||||||
D | 218 | 6 | 239 | 7 | |||||||||
Total | $ | 3,655 | 100 | % | $ | 3,567 | 100 | % |
March 31, 2013 | Estimated Fair Value | % | Gross Unrealized Losses | % | |||||||||
(In millions) | |||||||||||||
U.S. Government, Government agencies and Government-sponsored enterprises | $ | 864 | 25 | % | $ | 50 | 32 | % | |||||
AAA | 185 | 5 | 9 | 5 | |||||||||
AA | 600 | 18 | 50 | 32 | |||||||||
A | 412 | 12 | 6 | 4 | |||||||||
BBB | 774 | 23 | 25 | 16 | |||||||||
Non-Investment Grade | 567 | 17 | 18 | 11 | |||||||||
Total | $ | 3,402 | 100 | % | $ | 158 | 100 | % |
March 31, 2013 | Estimated Fair Value | % | Gross Unrealized Losses | % | |||||||||
Due in one year or less | $ | 206 | 6 | % | $ | 4 | 2 | % | |||||
Due after one year through five years | 914 | 27 | 25 | 16 | |||||||||
Due after five years through ten years | 1,182 | 35 | 61 | 39 | |||||||||
Due after ten years | 1,100 | 32 | 68 | 43 | |||||||||
Total | $ | 3,402 | 100 | % | $ | 158 | 100 | % |
March 31, 2013 | December 31, 2012 | ||||||||||||
(In millions) | Fair Value | Effective Duration (In years) | Fair Value | Effective Duration (In years) | |||||||||
Investments supporting Life & Group Non-Core | $ | 15,723 | 11.1 | $ | 15,590 | 11.3 | |||||||
Other interest sensitive investments | 28,651 | 4.1 | 28,855 | 3.9 | |||||||||
Total | $ | 44,374 | 6.6 | $ | 44,445 | 6.5 |
(In millions) | March 31, 2013 | December 31, 2012 | |||||
Short term investments: | |||||||
Commercial paper | $ | 345 | $ | 751 | |||
U.S. Treasury securities | 771 | 617 | |||||
Money market funds | 249 | 301 | |||||
Other | 190 | 163 | |||||
Total short term investments | $ | 1,555 | $ | 1,832 |
• | the risks and uncertainties associated with our loss reserves, as outlined in the Critical Accounting Estimates and the Reserves - Estimates and Uncertainties sections of our Annual Report on Form 10-K, including the sufficiency of the reserves and the possibility for future increases, which would be reflected in the results of operations in the period that the need for such adjustment is determined; |
• | the risk that the other parties to the transaction in which, subject to certain limitations, we ceded our legacy A&EP liabilities will not fully perform their obligations to CNA, the uncertainty in estimating loss reserves for A&EP liabilities and the possible continued exposure of CNA to liabilities for A&EP claims that are not covered under the terms of the transaction; |
• | the performance of reinsurance companies under reinsurance contracts with us; and |
• | the consummation of contemplated transactions and the successful integration of acquired operations. |
• | the impact of competitive products, policies and pricing and the competitive environment in which we operate, including changes in our book of business; |
• | product and policy availability and demand and market responses, including the level of ability to obtain rate increases and decline or non-renew under priced accounts, to achieve premium targets and profitability and to realize growth and retention estimates; |
• | general economic and business conditions, including recessionary conditions that may decrease the size and number of our insurance customers and create additional losses to our lines of business, especially those that provide management and professional liability insurance, as well as surety bonds, to businesses engaged in real estate, financial services and professional services, and inflationary pressures on medical care costs, construction costs and other economic sectors that increase the severity of claims; |
• | conditions in the capital and credit markets, including continuing uncertainty and instability in these markets, as well as the overall economy, and their impact on the returns, types, liquidity and valuation of our investments; |
• | conditions in the capital and credit markets that may limit our ability to raise significant amounts of capital on favorable terms, as well as restrictions on the ability or willingness of Loews to provide additional capital support to us; and |
• | the possibility of changes in our ratings by ratings agencies, including the inability to access certain markets or distribution channels and the required collateralization of future payment obligations as a result of such changes, and changes in rating agency policies and practices. |
• | regulatory initiatives and compliance with governmental regulations, judicial interpretations within the regulatory framework, including interpretation of policy provisions, decisions regarding coverage and theories of liability, trends in litigation and the outcome of any litigation involving us, and rulings and changes in tax laws and regulations; |
• | regulatory limitations, impositions and restrictions upon us, including the effects of assessments and other surcharges for guaranty funds and second-injury funds, other mandatory pooling arrangements and future assessments levied on insurance companies as well as the new federal financial regulatory reform of the insurance industry established by the Dodd-Frank Wall Street Reform and Consumer Protection Act; |
• | increased operating costs and underwriting losses arising from the Patient Protection and Affordable Care Act and the related amendments in the Health Care and Education Reconciliation Act, as well as health care reform proposals at the state level; and |
• | regulatory limitations and restrictions, including limitations upon our ability to receive dividends from our insurance subsidiaries, imposed by regulatory authorities, including regulatory capital adequacy standards. |
• | weather and other natural physical events, including the severity and frequency of storms, hail, snowfall and other winter conditions, natural disasters such as hurricanes and earthquakes, as well as climate change, including effects on weather patterns, greenhouse gases, sea, land and air temperatures, sea levels, rain and snow; |
• | regulatory requirements imposed by coastal state regulators in the wake of hurricanes or other natural disasters, including limitations on the ability to exit markets or to non-renew, cancel or change terms and conditions in policies, as well as mandatory assessments to fund any shortfalls arising from the inability of quasi-governmental insurers to pay claims; |
• | man-made disasters, including the possible occurrence of terrorist attacks and the effect of the absence or insufficiency of applicable terrorism legislation on coverages; |
• | the unpredictability of the nature, targets, severity or frequency of potential terrorist events, as well as the uncertainty as to our ability to contain our terrorism exposure effectively; and |
• | the occurrence of epidemics. |
CNA Financial Corporation | ||
Dated: April 30, 2013 | By | /s/ D. Craig Mense |
D. Craig Mense Executive Vice President and Chief Financial Officer |
Description of Exhibit | Exhibit Number |
Certification of Chief Executive Officer | 31.1 |
Certification of Chief Financial Officer | 31.2 |
Written Statement of the Chief Executive Officer of CNA Financial Corporation Pursuant to 18 U.S.C. Section 1350 (As adopted by Section 906 of the Sarbanes-Oxley Act of 2002) | 32.1 |
Written Statement of the Chief Financial Officer of CNA Financial Corporation Pursuant to 18 U.S.C. Section 1350 (As adopted by Section 906 of the Sarbanes-Oxley Act of 2002) | 32.2 |
XBRL Instance Document | 101.INS |
XBRL Taxonomy Extension Schema | 101.SCH |
XBRL Taxonomy Extension Calculation Linkbase | 101.CAL |
XBRL Taxonomy Extension Definition Linkbase | 101.DEF |
XBRL Taxonomy Label Linkbase | 101.LAB |
XBRL Taxonomy Extension Presentation Linkbase | 101.PRE |
1. | I have reviewed this quarterly report on Form 10-Q of CNA Financial Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Dated: | April 30, 2013 | By | /s/ Thomas F. Motamed | |
Thomas F. Motamed | ||||
Chief Executive Officer |
1. | I have reviewed this quarterly report on Form 10-Q of CNA Financial Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Dated: | April 30, 2013 | By | /s/ D. Craig Mense | |
D. Craig Mense | ||||
Chief Financial Officer |
• | the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2013 filed on the date hereof with the Securities and Exchange Commission (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
• | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: | April 30, 2013 | By | /s/ Thomas F. Motamed | |
Thomas F. Motamed | ||||
Chief Executive Officer |
• | the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2013 filed on the date hereof with the Securities and Exchange Commission (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
• | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: | April 30, 2013 | By | /s/ D. Craig Mense | |
D. Craig Mense | ||||
Chief Financial Officer |
Derivative Financial Instruments (Summary of recognized gains (losses) related to derivative financial instruments) (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | |
---|---|---|
Mar. 31, 2013
|
Mar. 31, 2012
|
|
Recognized Gains (Losses) | ||
Derivative instruments not designated as hedging instruments, gain (loss), net | $ 2 | $ (1) |
Gain (loss) on derivative instruments, net, pretax | 2 | |
Currency forwards [Member]
|
||
Recognized Gains (Losses) | ||
Derivative instruments not designated as hedging instruments, gain (loss), net | 2 | (1) |
Futures sold, not yet purchased [Member]
|
||
Recognized Gains (Losses) | ||
Gain (loss) on derivative instruments held for trading purposes, net | $ 1 |
Claim and Claim Adjustment Expense Reserves (Net prior year claim and allocated claim adjustment expense reserve development for CNA Specialty segment) (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | |
---|---|---|
Mar. 31, 2013
|
Mar. 31, 2012
|
|
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development, excluding Life & Group | $ (26) | $ (18) |
CNA Specialty [Member]
|
||
Medical Professional Liability | (3) | (6) |
Other Professional Liability | (1) | 4 |
Surety | 1 | 1 |
Warranty | (1) | |
Other | (12) | (4) |
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development, excluding Life & Group | $ (15) | $ (6) |
Claim and Claim Adjustment Expense Reserves (Narrative) (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | |
---|---|---|
Mar. 31, 2013
|
Mar. 31, 2012
|
|
Catastrophe losses net of reinsurance | $ 39 | $ 28 |
Investments (Components of other-than-temporary impairment losses recognized in earnings) (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | |
---|---|---|
Mar. 31, 2013
|
Mar. 31, 2012
|
|
Net other-than-temporary impairment losses recognized in earnings | $ 18 | $ 27 |
Corporate and other bonds [Member]
|
||
Net other-than-temporary impairment losses recognized in earnings | 3 | 10 |
Residential mortgage-backed [Member]
|
||
Net other-than-temporary impairment losses recognized in earnings | 14 | |
U.S. Treasury and obligations of government-sponsored enterprises [Member]
|
||
Net other-than-temporary impairment losses recognized in earnings | 1 | |
Total fixed maturity securities available-for-sale [Member]
|
||
Net other-than-temporary impairment losses recognized in earnings | 3 | 25 |
Common stock [Member]
|
||
Net other-than-temporary impairment losses recognized in earnings | 2 | |
Preferred stock [Member]
|
||
Net other-than-temporary impairment losses recognized in earnings | 15 | |
Total equity securities available-for-sale [Member]
|
||
Net other-than-temporary impairment losses recognized in earnings | $ 15 | $ 2 |
Other Intangible Assets (Tables)
|
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other Intangible Assets [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of other intangible assets | Other intangible assets are presented in the following table.
|
Benefit Plans (Components of net periodic cost (benefit)) (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | |
---|---|---|
Mar. 31, 2013
|
Mar. 31, 2012
|
|
Pension Plans, Defined Benefit [Member]
|
||
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract] | ||
Service cost | $ 3 | $ 3 |
Interest cost on projected benefit obligation | 30 | 34 |
Expected return on plan assets | (45) | (43) |
Amortization of net actuarial (gain) loss | 12 | 10 |
Net periodic cost (benefit) | 4 | |
Other Postretirement Benefit Plans, Defined Benefit [Member]
|
||
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract] | ||
Amortization of prior service credit | (4) | (4) |
Net periodic cost (benefit) | $ (4) | $ (4) |
Fair Value (Assets and liabilities measured at fair value on a recurring basis) (Details) (USD $)
In Millions, unless otherwise specified |
Mar. 31, 2013
|
Dec. 31, 2012
|
---|---|---|
Fixed maturity securities | $ 42,799 | $ 42,633 |
Equity securities | 201 | 249 |
Other invested assets | 49 | 59 |
Short term investments | 1,555 | 1,832 |
Separate account business | 279 | 312 |
Derivative financial instruments, included in Other liabilities | (1) | (3) |
Fair Value, Measurements, Recurring [Member]
|
||
Fixed maturity securities | 42,799 | 42,633 |
Equity securities | 201 | 249 |
Other invested assets | 49 | 59 |
Short term investments | 1,504 | 1,792 |
Life settlement contracts, included in Other assets | 95 | 100 |
Separate account business | 279 | 312 |
Total assets | 44,927 | 45,145 |
Derivative financial instruments, included in Other liabilities | (1) | (3) |
Total liabilities | (1) | (3) |
Fair Value, Measurements, Recurring [Member] | Corporate and other bonds [Member]
|
||
Fixed maturity securities | 22,354 | 22,236 |
Fair Value, Measurements, Recurring [Member] | States, municipalities and political subdivisions [Member]
|
||
Fixed maturity securities | 10,948 | 10,783 |
Fair Value, Measurements, Recurring [Member] | Residential mortgage-backed [Member]
|
||
Fixed maturity securities | 5,683 | 5,920 |
Fair Value, Measurements, Recurring [Member] | Commercial mortgage-backed [Member]
|
||
Fixed maturity securities | 1,990 | 1,822 |
Fair Value, Measurements, Recurring [Member] | Other asset-backed [Member]
|
||
Fixed maturity securities | 955 | 952 |
Fair Value, Measurements, Recurring [Member] | Total asset-backed [Member]
|
||
Fixed maturity securities | 8,628 | 8,694 |
Fair Value, Measurements, Recurring [Member] | U.S. Treasury and obligations of government-sponsored enterprises [Member]
|
||
Fixed maturity securities | 181 | 182 |
Fair Value, Measurements, Recurring [Member] | Foreign government [Member]
|
||
Fixed maturity securities | 552 | 613 |
Fair Value, Measurements, Recurring [Member] | Redeemable preferred stock [Member]
|
||
Fixed maturity securities | 136 | 125 |
Fair Value, Measurements, Recurring [Member] | Level 1 [Member]
|
||
Fixed maturity securities | 342 | 344 |
Equity securities | 120 | 117 |
Other invested assets | ||
Short term investments | 1,102 | 987 |
Life settlement contracts, included in Other assets | ||
Separate account business | 11 | 4 |
Total assets | 1,575 | 1,452 |
Derivative financial instruments, included in Other liabilities | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Corporate and other bonds [Member]
|
||
Fixed maturity securities | 32 | 6 |
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | States, municipalities and political subdivisions [Member]
|
||
Fixed maturity securities | ||
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Residential mortgage-backed [Member]
|
||
Fixed maturity securities | ||
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Commercial mortgage-backed [Member]
|
||
Fixed maturity securities | ||
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Other asset-backed [Member]
|
||
Fixed maturity securities | ||
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Total asset-backed [Member]
|
||
Fixed maturity securities | ||
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | U.S. Treasury and obligations of government-sponsored enterprises [Member]
|
||
Fixed maturity securities | 155 | 158 |
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Foreign government [Member]
|
||
Fixed maturity securities | 104 | 140 |
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Redeemable preferred stock [Member]
|
||
Fixed maturity securities | 51 | 40 |
Fair Value, Measurements, Recurring [Member] | Level 2 [Member]
|
||
Fixed maturity securities | 40,977 | 41,038 |
Equity securities | 62 | 98 |
Other invested assets | 49 | 58 |
Short term investments | 397 | 799 |
Life settlement contracts, included in Other assets | ||
Separate account business | 266 | 306 |
Total assets | 41,751 | 42,299 |
Derivative financial instruments, included in Other liabilities | (2) | |
Total liabilities | (2) | |
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Corporate and other bonds [Member]
|
||
Fixed maturity securities | 22,020 | 22,011 |
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | States, municipalities and political subdivisions [Member]
|
||
Fixed maturity securities | 10,819 | 10,687 |
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Residential mortgage-backed [Member]
|
||
Fixed maturity securities | 5,233 | 5,507 |
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Commercial mortgage-backed [Member]
|
||
Fixed maturity securities | 1,813 | 1,693 |
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Other asset-backed [Member]
|
||
Fixed maturity securities | 559 | 584 |
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Total asset-backed [Member]
|
||
Fixed maturity securities | 7,605 | 7,784 |
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | U.S. Treasury and obligations of government-sponsored enterprises [Member]
|
||
Fixed maturity securities | 26 | 24 |
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Foreign government [Member]
|
||
Fixed maturity securities | 448 | 473 |
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Redeemable preferred stock [Member]
|
||
Fixed maturity securities | 59 | 59 |
Fair Value, Measurements, Recurring [Member] | Level 3 [Member]
|
||
Fixed maturity securities | 1,480 | 1,251 |
Equity securities | 19 | 34 |
Other invested assets | 1 | |
Short term investments | 5 | 6 |
Life settlement contracts, included in Other assets | 95 | 100 |
Separate account business | 2 | 2 |
Total assets | 1,601 | 1,394 |
Derivative financial instruments, included in Other liabilities | (1) | (1) |
Total liabilities | (1) | (1) |
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Corporate and other bonds [Member]
|
||
Fixed maturity securities | 302 | 219 |
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | States, municipalities and political subdivisions [Member]
|
||
Fixed maturity securities | 129 | 96 |
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Residential mortgage-backed [Member]
|
||
Fixed maturity securities | 450 | 413 |
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Commercial mortgage-backed [Member]
|
||
Fixed maturity securities | 177 | 129 |
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Other asset-backed [Member]
|
||
Fixed maturity securities | 396 | 368 |
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Total asset-backed [Member]
|
||
Fixed maturity securities | 1,023 | 910 |
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | U.S. Treasury and obligations of government-sponsored enterprises [Member]
|
||
Fixed maturity securities | ||
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Foreign government [Member]
|
||
Fixed maturity securities | ||
Fair Value, Measurements, Recurring [Member] | Level 3 [Member] | Redeemable preferred stock [Member]
|
||
Fixed maturity securities | $ 26 | $ 26 |
Investments (Contractual maturity) (Details) (USD $)
In Millions, unless otherwise specified |
Mar. 31, 2013
|
Dec. 31, 2012
|
---|---|---|
Cost or Amortized Cost | ||
Due in one year or less, cost or amortized cost | $ 1,783 | $ 1,648 |
Due after one year through five years, cost or amortized cost | 12,916 | 13,603 |
Due after five years through ten years, cost or amortized cost | 9,430 | 8,726 |
Due after ten years, cost or amortized cost | 14,341 | 14,164 |
Total Amortized Cost Basis | 38,470 | 38,141 |
Estimated Fair Value | ||
Due in one year or less, estimated fair value | 1,819 | 1,665 |
Due after one year through five years, estimated fair value | 13,731 | 14,442 |
Due after five years through ten years, estimated fair value | 10,267 | 9,555 |
Due after ten years, estimated fair value | 16,919 | 16,942 |
Total Estimated Fair Value | $ 42,736 | $ 42,604 |
Other Intangible Assets Schedule of Other Intangible Assets (Details) (USD $)
In Millions, unless otherwise specified |
Mar. 31, 2013
|
Dec. 31, 2012
|
---|---|---|
Finite-lived intangible assets | $ 79 | $ 83 |
Accumulated amortization | 54 | 43 |
Indefinite-lived intangible assets | 69 | 73 |
Total other intangible assets | 148 | 156 |
Total intangible assets, accumulated amortization | 54 | 43 |
Value of business acquired [Member]
|
||
Finite-lived intangible assets | 59 | 62 |
Accumulated amortization | 52 | 43 |
Trade name [Member]
|
||
Finite-lived intangible assets | 8 | 8 |
Accumulated amortization | 1 | |
Distribution channel [Member]
|
||
Finite-lived intangible assets | 12 | 13 |
Accumulated amortization | $ 1 |
Earnings (loss) per share
|
3 Months Ended |
---|---|
Mar. 31, 2013
|
|
Earnings Per Share [Abstract] | |
Earnings Per Share | Note B. Earnings Per Share Earnings per share is based on the weighted average number of outstanding common shares. Basic earnings (loss) per share excludes the impact of dilutive securities and is computed by dividing Net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For the three months ended March 31, 2013 and 2012, approximately 372 thousand and 339 thousand potential shares attributable to exercises under stock-based employee compensation plans were included in the calculation of diluted earnings per share. For those same periods, approximately 335 thousand and 668 thousand potential shares attributable to exercises under stock-based employee compensation plans were not included in the calculation of diluted earnings per share because the effect would have been antidilutive. |